Clinical Trial Update: Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating Nyaditum Resae as a co-adjuvant during active pulmonary tuberculosis treatment and its impact on the gut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• Nyaditum Resae

Snippet

Sponsor: University of Stellenbosch | Conditions: Tuberculosis | NA | Status: ACTIVE_NOT_RECRUITING